Long-time Collaborators Botond Roska and José-Alain Sahel Win International Prize for Translational Neuroscience
June 22, 2023 03:00 ET
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Basel, Switzerland, June 22, 2023 --In recognition of their pioneering work on restoring vision to blind patients using optogenetic therapy, Botond Roska and José-Alain Sahel were today awarded the...
Researchers Discover a New Embryonic Brain Circuit
April 13, 2023 10:54 ET
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
EMBARGOED UNTIL 17-APR-2023 11:00 ET The findings may provide new insights into circuit abnormalities in autism. ...
New sequencing method developed at IOB has potential to become universal tool of choice
May 30, 2022 11:30 ET
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Media Release New sequencing method developed at IOB has potential to become universal tool of choice A new single-cell RNA-sequencing protocol developed at IOB enables the...
Das bewusstlose Gehirn ist alles andere als «stumm»
May 12, 2022 01:00 ET
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Die Grosshirnrinde gilt als zentrale Hirnregion für bewusste Verarbeitung. Während einer Vollnarkose wird dieser Bereich jedoch nicht lahmgelegt: Bestimmte Neurone zeigen dann sogar eine höhere...
Roska group researchers find: When unconscious, the brain is anything but ‘silent’
May 12, 2022 01:00 ET
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
The cerebral cortex is thought to be the seat of conscious processing in the brain. Rather than being inactivated, specific cells in the cortex show higher spontaneous activity during general...
Optogenetische Gentherapie lässt Erblindeten partiell wieder Sehen
May 24, 2021 11:00 ET
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Ein internationales Forschungsteam konnte zeigen, dass eine optogenetische Gentherapie bei einem wegen erblicher Retinitis pigmentosa erblindeten Patienten dazu beiträgt, einen Teil der Sehkraft...
Optogenetic Methods Restore Partial Vision in a Blind Patient
May 24, 2021 11:00 ET
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
An international research team has shown that optogenetic therapy has helped to partially regain visual function in a patient with retinitis pigmentosa. This is a milestone towards a gene therapy that...